Tumor-associated myeloid regulatory cells

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/11

encourage image

There's no tags or description

Looks like no tags are added yet.

12 Terms

1
New cards

The tumor microenvironment can block normal myeloid differentiation/maturation and skew myeloid cells toward immunosuppressive phenotypes. Why?

Mature DC/M1- Immunogenic and anti-angiogenic.

Immature DC/M1- Tolerogenic & pro angiogenic

2
New cards

What are Myeloid-derived suppressor cells — MDSCs. How are they formed

Myelopoiesis in bone marrow: monocytes → macrophages/DCs and granulocytes → neutrophils

Cancer-associated factors- VEGF and IL-6- can disrupt normal differentiation of IMMATURE MYELOID CELLS

Results in Immature myeloid cells accumulation.

These are called: MDSC

Tumor-derived inflammatory signals → abnormal myelopoiesis → accumulation of MDSCs → immunosuppression.

3
New cards

How does chronic inflammation aid in cancer progression with relation to MDSC

chronic inflammation → expansion/activation of suppressive myeloid cells → causes suppression of anti-tumor immunity too → tumor gets an advantage.

4
New cards

Explain 3 MDSC Suppressive effector mechanisms/

How MDSCs become suppressive

1. ARG1 pathway — starve T cells of arginine

MDSC ↑ ARG1 → breaks down L-arginine → ↓ L-arginine available to T cells → ↓ CD3ζ/TCR function + ↓ T-cell proliferation → T-cell suppression

Memory: ARG1 = arginine starvation.

2. NOS2 pathway — make nitric oxide (NO)

MDSC ↑ NOS2 → uses L-arginine to produce NO → ↓ IL-2 signaling/proliferation + ↑ T-cell apoptosis → T-cell suppression

3. ROS pathway — oxidative damage

MDSC produces ROS → oxidative stress/damage to T-cell signaling → ↓ CD3ζ + ↓ proliferation + ↑ apoptosis → T-cell suppression


By activating pathways that release cytokines/proteins that downregulates T cells and leads to apoptosis or suppression

5
New cards



6
New cards

Function of MDSC

  • Suppress T cells

  • Promote angiogenesis

  • Invasion

  • Promote metastasis

  • Pre Metastatic niche formation


7
New cards

Explain how MDSC performs Pre Metastatic niche formation

Accumalation at distant site

NET - to capture the tumour antigen (neutrophil extracellular traps)

ROS and inflammatory signalling for creating a tme

Matric remodelling

Immunosuppressive environment

NK cell killing inhibition

Extravasation from the primary site

8
New cards

What are the 3 Specific strategies against MDSCs

1. Force MDSC differentiation
ATRA → MDSCs differentiate into mature DCs/macrophages → ↓ immunosuppressive MDSCs → ↑ antitumor immunity

2. Block MDSC expansion/recruitment
VEGF blockade → ↓ MDSC recruitment/infiltration into tumor → ↓ immune suppression → ↑ antitumor immunity

3. Block MDSC suppressive function
COX-2 inhibition → ↓ MDSC expansion + ↓ ARG1 expression → ↓ T-cell suppression → ↑ antitumor immunity

9
New cards

How can MDSCs be therapeutically targeted?

A. Deplete MDSCs — remove them
Low-dose chemotherapy → ↓ MDSC numbers → ↓ T-cell suppression → ↑ antitumor immunity

B. Inhibit MDSC recruitment — keep them out of the tumor
CXCR2 or CXCR4 blockade → ↓ MDSC migration into tumor → ↓ immunosuppression → ↑ antitumor immunity

C. Reprogram/disable MDSCs — stop their suppressive functions
ARG1 inhibition / COX-2 inhibition → ↓ MDSC suppressive activity → ↑ T-cell activity → ↑ antitumor immunity

10
New cards

Name 3 Drugs targeting MDSC expansion/recruitment

knowt flashcard image
11
New cards

Reducing inflammation might delay MSDC accumulation→inhibit tumor progression. true or false

True

12
New cards

How does Viagra/Sildenafil be involved in MDSC suppression

Sildenefil is a PDE5 inhibitor→ interference with MDSC suppressive pathways (Increased arginine and nitric oxide) → potentially improve anti-tumor immune activity.

<p>Sildenefil is a PDE5 inhibitor→ interference with MDSC suppressive pathways (Increased arginine and nitric oxide) → potentially improve anti-tumor immune activity.</p>